GlassScriptPhysician profile
Joan J Lee
NPI 1639494289
$1,099.35
in general payments reported to CMS, 2019-2025
17 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.22 · 2020: $26.23 · 2021: $113 · 2022: $148 · 2023: $218 · 2024: $127 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $220.12 | 2019-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $188.55 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $133.72 | 2023-2025 | Tryptyr, Clareon, Clareon Panoptix Pro |
| Tarsus Pharmaceuticals, INC. | $104.00 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $84.27 | 2021-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $65.05 | 2022-2025 | Iluvien, Purified Cortrophin Gel |
| Eyepoint US, INC. | $58.31 | 2022 | |
| Horizon Therapeutics Plc | $40.42 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.85 | 2019-2022 | |
| Allergan, INC. | $37.76 | 2019-2021 | |
| Harrow Eye, LLC | $33.20 | 2024-2025 | Iheezo |
| Coherus Oncology, INC. | $22.87 | 2023 | |
| Oyster Point Pharma, INC. | $16.46 | 2023 | Tyrvaya |
| Abbvie INC. | $15.15 | 2023 | |
| Mallinckrodt Enterprises LLC | $14.83 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.57 | 2022 | |
| Biotissue Holdings INC. | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.